USPTO serial 87916980
ICPD INSTITUTE FOR CLINICAL PHARMACODYNAMICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 1, 2019
- Examiner
- RYDLAND, STEPHANIE DIANA
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ICPD INSTITUTE FOR CLINICAL PHARMACODYNAMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Schenectady, NY
Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
Schenectady, NY
Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
Schenectady, NY
Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rosemary Weaver McKenna
Rosemary Weaver McKenna Hacker Murphy, LLP28 Second Street, Suite 90128 Second StreetTroy, NY 12180Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical drug development services, pharmaceutical research services, pharmaceutical product evaluation, conducting early evaluations in the field of new pharmaceuticals, consultancy pertaining to pharmacology, pharmacokinetic and pharmacokinetic-pharmacodynamic studies and analyses relating to drug development | ACTIVE | Dec 31, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
- Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
- Other trademarks owned by INSTITUTE FOR CLINICAL PHARMACODYNAMICS,INC.
- Other trademarks in Class 042
- Similar marks named ICPD INSTITUTE FOR CLINICAL PHARMACODYNAMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 17, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 17, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 19, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 1, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 1, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 5, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 4, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 4, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Apr 29, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 29, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 11, 2018 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 11, 2018 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 11, 2018 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Sep 11, 2018 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Sep 4, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 19, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2018 | NWAP | NEW APPLICATION ENTERED | — |